←Back to Expert Scholars
Translational Medicine / 转化医学MDS, Molecular Classification
Luca Malcovati
MD
🏢University of Pavia🌐Italy
Professor of Hematology
80
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Luca Malcovati is a leader in MDS molecular classification at Pavia and co-developed the molecular IPSS (IPSS-M) integrating gene mutations into risk prediction. He has defined SF3B1-mutant MDS as a distinct entity. His work has driven the genomic era of MDS classification.
Share:
🧪Research Fields 研究领域
MDS molecular classification
IPSS-M
SF3B1 MDS
MDS genomics
myelodysplastic syndromes
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Luca Malcovati 的研究动态
Follow Luca Malcovati's research updates
留下邮箱，当我们发布与 Luca Malcovati（University of Pavia）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment